T-MAXIMUM
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneic immune cells.
T-MAXIMUM
Industry:
Biotechnology Health Care Product Research
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.t-maximum.com
Status:
Active
Contact:
400-9600-652
Email Addresses:
[email protected]
Total Funding:
0
Investors List
Hongfeng Investment Management
Hongfeng Investment Management investment in Angel Round - T-Maximum
Haibang Capital
Haibang Capital investment in Angel Round - T-Maximum
Official Site Inspections
http://www.t-maximum.com
- Host name: 155.102.130.200
- IP address: 155.102.130.200
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
Loading ... 